ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, we established dasatinib‐resistant cell lines using BCR::ABL1‐positive human CML cell lines K562 and KU812 and investigated the mechanism of dasatinib‐acquired resistance.